Ex spy chief Sir Andrew Parker joins board of Babcock International 

Ex spy chief Sir Andrew Parker joins board of military contractor Babcock International By Daily Mail City & Finance Reporter Published: 22:16 GMT, 10 November 2020 | Updated: 22:16 GMT, 10 November 2020 Former spy chief Sir Andrew Parker has joined the board of military contractor Babcock International. Parker, 58, was MI5’s director general for … Read more

MARKET REPORT: Capita rockets 27% as cost cutting lifts profits

Investors piled into Capita after a cost-cutting plan offset some of the losses it racked up from the pandemic. Around £100million was wiped off the government contractor’s turnover in the three months up to the end of September. It brought in revenues of £803million, down from £902million in the same period last year. Around £100million … Read more

Property giants pin hopes on Covid vaccine to ease the pressure

Property giants pin hopes on Covid vaccine as commercial landlord Land Securities unveils £1bn write-down By Matt Oliver For The Daily Mail Published: 22:15 GMT, 10 November 2020 | Updated: 22:15 GMT, 10 November 2020 Property bosses are pinning their hopes on a Covid-19 vaccine to ease pressure on the industry after Britain’s biggest commercial … Read more

Investment sites hit by trading rush after Pfizer vaccine announcement

Investors locked out of trading sites as they scramble to capitalise on Pfizer’s vaccine announcement By Fiona Parker For The Daily Mail Published: 21:55 GMT, 9 November 2020 | Updated: 22:20 GMT, 9 November 2020 Investors were yesterday locked out of some of Britain’s largest trading platforms as they rushed to capitalise on Pfizer’s vaccine … Read more

British drug giants Astrazeneca and GSK still in race for a Covid jab

British drug giants Astrazeneca and Glaxosmithkline still in the race for a Covid jab By Matt Oliver For The Daily Mail Published: 21:53 GMT, 9 November 2020 | Updated: 22:20 GMT, 9 November 2020 Britain’s two biggest drugs companies are also developing Covid-19 vaccines. Potential jabs are being tested by FTSE 100 giants Astrazeneca and … Read more